MedTrace Logo

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

NCT07171658 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4500

Last updated 2025-12-22

No results posted yet for this study

Summary

The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland.

This randomized trial will compare three arms:

1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.
2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection
3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.

Conditions

  • Cervical Cancer Screening

Interventions

BEHAVIORAL

Sensitization to Cervical Cancer (CC) screening

Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.

BEHAVIORAL

Home-based HPV self-sampling

Women will receive a free-of-charge vaginal self-sampling kit for HPV infection.

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER

  • Jessica Di Vincenzo Sormani

    lead OTHER

Principal Investigators

  • Jessica Di Vincenzo Sormani, PhD · Haute École de Santé de Genève (HEdS-GE)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-07
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07171658 on ClinicalTrials.gov